Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
Abstract Familial adult myoclonus epilepsy (FAME) management relies on antiseizure medications (ASMs), which inadequately address myoclonus and cortical tremor. This study evaluates Perampanel (PER), an AMPA‐receptor antagonist, for treating FAME symptoms. Fifteen FAME2 patients participated in an o...
Saved in:
Main Authors: | Antonietta Coppola, Claudia Cuccurullo, Gianmaria Senerchia, Marica Rubino, Liana Veneziano, Francesco Brancati, Luigi Baratto, Valentina Virginia Iuzzolino, Leonilda Bilo, Pasquale Striano, Raffaele Dubbioso |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.13100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01) -
Acupuncture for somatosensory deficits after stroke: a systematic review and meta-analysis
by: Shumeng Ren, et al.
Published: (2025-02-01) -
Myoclonic status epilepticus with dystonia-like symptoms in patients with dementia: Report of two cases
by: Rosario V. Rossi, et al.
Published: (2025-03-01) -
Acute respiratory failure induced by belly dancer’s syndrome: A glance to a rare case report
by: Ruth Elizabeth Abraham, et al.
Published: (2023-07-01) -
CLN6‐related continuum phenotype caused by aberrant splicing
by: Federica Invernizzi, et al.
Published: (2025-02-01)